¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"long lived lymphocytes"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • apical long axis view
    ½É÷ÀåÃ൵
  • long acting
    Àå½Ã°£ÀÛ¿ë-, Áö¼Ó¼º-
  • long acting insulin
    Áö¼ÓÀÛ¿ëÀν¶¸°
  • long bone
    ±ä»À, Àå°ñ
  • long ciliary nerve
    ±ä¼¶¸ðü½Å°æ, Àå¼¶¸ðü½Å°æ
  • long distance irradiation
    Àå°Å¸®Á¶»ç
  • long nasopalatine nerve
    ±äÄÚÀÔõÀå½Å°æ, Àåºñ±¸°³½Å°æ
  • long QT syndrome
    ±äQTÁõÈıº
  • long thoracic nerve
    ±ä°¡½¿½Å°æ, ÀåÈä½Å°æ
  • long tract sign
    ±ä½Å°æ·Î¡ÈÄ
  • long-acting thyroid stimulator
    Áö¼Ó°©»ó»ùÀڱع°Áú, Áö¼Ó°©»ó¼±Àڱع°Áú
  • long-arm cast
    ±äÆÈ¼®°íºØ´ë
  • long-leg cast
    ±ä´Ù¸®¼®°íºØ´ë
  • long-term care
    Àå±â¿ä¾ç¼­ºñ½º
  • long-term illness
    Àå±âÁúȯ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • long bone
    ±ä»À
  • long-term care
    Àå±â¿ä¾ç¼­ºñ½º
  • parasternal long axis view
    º¹Àå»ÀÁÖÀ§±äÃà´Ü¸éµµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • short lived lymphocyte
    ´Ü»ý¸²ÇÁ±¸, ªÀº¼ö¸í¸²ÇÁ±¸
  • apical long axis view
    ½ÉÀ峡ÀåÃà´Ü¸éµµ
  • long bone
    ±ä»À
  • long acting insulin
    Áö¼ÓÀν¶¸°
  • long distance irradiation
    Àå°Å¸®Á¶»ç
  • long v illness
    Àå±âÁúȯ
  • long acting
    Àå½Ã°£ÀÛ¿ë-, Áö¼Ó¼º-
  • long sitting
    ´Ù¸®»¸°í¾É±â
  • long sleeper
    ÀḹÀº»ç¶÷
  • long ciliary nerve
    ±ä¼¶¸ðü½Å°æ
  • long nasopalatine nerve
    ±äÄÚÀÔõÀå½Å°æ
  • long thoracic nerve
    ±ä°¡½¿½Å°æ
  • long-acting thyroid stimulator
    Áö¼Ó¹æÆÐ»ùÀڱع°Áú, Áö¼Ó°©»ó»ùÀڱع°Áú
  • long-term potentiation
    ÀÚ±â»ó½ÂÀÛ¿ë
  • parasternal long axis view
    Èä°ñ¿¬ÀåÃà´Ü¸éµµ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Lymphocytes
    ¸²ÇÁ±¸(¡­Ï¹)
  • LATS =long acting thyroid stimulator
    Áö¼Ó¼º °©»ó¼±Àڱع°Áú.
  • LATS=long acting thyroid stimulator
    Áö¼Ó¼º °©»ó¼± Àڱع°Áú.
  • LTD = long term depression
    Àå±âÀû(íþÑ¢îÜ) ¾ïÁ¦(åäð¤)
  • LTP = long term potentiation
    Àå±âÀû(íþÑ¢îÜ) Ȱ¼ºÈ­(üÀàõûù)
  • Long-loop feedback
    Àåȯ(íóü») µÇ¸ÔÀ̱â
  • Long-term depression
    Àå±â(íþÑ¢) ¿ì¿ïÁõ(éØê¦ñø)
  • Long-term memory
    Àå±â±â¾ï(íþÑ¢ÑÀåã)
  • Long-term potentiation
    Àڱ⠻ó½ÂÀÛ¿ë(ßÓã«íÂéÄ)
  • Q-T prolongation syndrome ; long Q-T syndrome
    Q-T°£°Ý ¿¬ÀåÁõÈıº.
  • apical long axis view
    ½É÷ÀåÃà´Ü¸éµµ.
  • incus, long process
    ¸ð·ç°ñ±ä´Ù¸®, ħ°ñÀå°¢.
  • incus, long process of
    ħ°ñÀå°¢, ¸ð·ç°ñ±ä´Ù¸®{ÇØ}
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • long lived lymphocytes
    Àå»ý¸²ÇÁ±¸(ËöË×?Ë´).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • short lived lymphocytes
    ´Ü»ý¸²ÇÁ±¸.
  • thymus-derived lymphocytes
  • apical long axis view
    ½É÷ÀåÃà´Ü¸éµµ.
  • course of long duration
    ±ä°æ°ú, Àå°æ°ú(íþÌèΦ).
  • incus, long process
    ¸ð·ç°ñ±ä´Ù¸®, ħ°ñÀå°¢.
  • incus, long process of
    ħ°ñÀå°¢, ¸ð·ç°ñ±ä´Ù¸®{ÇØ}
  • long (insular) gyrus
    ±ä(¼¶)À̶û
  • long TR image
    ±ä(Àå) ¹Ýº¹½Ã°£ ¿µ»ó
  • long acting
    Àå½Ã°£ÀÛ¿ë(íþãÁÊàíÂéÄ)ÀÇ, Áö¼Ó¼ºÀÇ.
  • long acting drug
    Áö¼Ó¼º¾à(ò¥áÙàõå·).
  • long acting insulin
    Áö¼Ó¼º Àν¶¸°.
  • long acting sulfonamide
    Áö¼Ó¼º ¼³ÆÄÁ¦.
  • long acting thyroid stimulator =LATS
    Àå±âÀÛ¿ë°©»ó¼±Àڱع°Áú(íþÑ¢íÂéÄ Ë£ßÒàÍô§Ð½Úªòõ).
  • long adductor muscle ³ª musculus adductor longus
    Àå³»Çâ±Ù, Àå³»Àü±Ù( íþÒ®ï®ÐÉ).
  • long arm
    ±äÆÈ, Àå¿Ï(íþèÓ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Long (insular) gyrus
    ±ä(¼¶)À̶û
    [¿¾ ¿ë¾î] µµÀåȸ
  • Long thoracic nerve
    ±ä°¡½¿½Å°æ
    [¿¾ ¿ë¾î] ÀåÈä½Å°æ
  • Long head
    ±ä°¥·¡
    [¿¾ ¿ë¾î] ÀåµÎ
  • Long portal vein
    ±ä³úÇϼöü¹®¸Æ
    [¿¾ ¿ë¾î] ÇϼöüÀå¹®¸Æ
  • Long posterior ciliary arteries
    ±äµÚ¼¶¸ðüµ¿¸Æ
    [¿¾ ¿ë¾î] ÀåÈĸð¾çüµ¿¸Æ
  • Long capillary loop
    ±ä¸ð¼¼Ç÷°ü°í¸®
    [¿¾ ¿ë¾î] Àå¸ð¼¼Ç÷°ü°í¸®
  • Long plantar ligament
    ±ä¹ß¹Ù´ÚÀδë
    [¿¾ ¿ë¾î] ÀåôÀδë
  • Long ciliary nerve
    ±ä¼¶¸ðü½Å°æ
    [¿¾ ¿ë¾î] Àå¸ð¾çü½Å°æ
  • Long central artery
    ±äÁ߽ɵ¿¸Æ
    [¿¾ ¿ë¾î] ÀåÁ߽ɵ¿¸Æ
  • Long nasopalatine nerve
    ±äÄÚÀÔõÀå½Å°æ
    [¿¾ ¿ë¾î] Àåºñ±¸°³½Å°æ
  • Long bone
    ±ä»À
    [¿¾ ¿ë¾î] Àå°ñ
  • Long crus
    ±ä´Ù¸®
    [¿¾ ¿ë¾î] Àå°¢
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • long-acting thyroid stimulator
    Áö¼Ó¼º(ò¥áÙàõ) °©»ó¼±ÀÚ±ØÁ¦(Ë£ßÒàÍí©Ð½ð­)
  • long-chain base
    ±ä»ç½½ ¿°(ç¤)
  • long-chain fatty acid thiokinase
    ±ä»ç½½Áö¹æ»ê(ò·Û¸ß«) Ƽ¿ÀÄ«À̳×À̽º
  • long interspersed repeated sequence
    Àå»êÀç ¹Ýº¹ ¼­¿­(íþߤî¤ÚãÜÖßíÖª)
  • long patch pathway
    ÀåÆí °æ·Î(íþø¹ÌèÖØ)
  • long period intersperion
    Àå±â »êÀç(íþѢߤî¤)
  • long-range hydration
    ¿ø°Å¸® ¼öÈ­(êÀËå×îâ©ûù)
  • long-range interaction
    ¿ø°Å¸® »óÈ£ÀÛ¿ë(êÀËå×îßÓû»íÂéÄ)
  • long space fibril
    ±ä°ø°£(ÍöÊà) È­À̺긱
  • long spacing segment
    ±ä°ø°£ ºÐÀý(ÍöÊàÝÂï½)
  • long terminal repeat
    Àå ¸»´Ü¹Ýº¹(íþØÇÓ®ÚãÜÖ)
  • very long-chain fatty acids
    ¸Å¿ì ±ä »ç½½ Áö¹æ»ê(ò·Û¸ß«)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • long bone
    Àå°ñ
  • long head of biceps muscle of thigh
    ´ëÅðÀ̵αÙÀåµÎ
  • long term
    Àå±â°£
  • long TR image
    ±ä ¹Ýº¹½Ã°£¿µ»ó
  • long-term storage
    Àå±âÀúÀå(ÀåÄ¡)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
CBL circulating blood lymphocytes; chronic blood loss; cord blood leukocytes
LML large and medium lymphocytes; left mediolateral; left middle lobe
Ly a T-cell antigen used for grouping T-lymphocytes into different classes
PAL pathology laboratory; peptidyl-alpha-hydroxyglycine alpha-amidating lysine phase alteration plane; p...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CBL Cord blood lymphocytes
CTL Cytotoxic T Lymphocytes
CL Cytotoxic T lymphocytes
CTL Cytotoxic thymus-derived lymphocytes
GIL Graft-infiltrating lymphocytes
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • long
    ±ä
  • long acting drug
    Áö¼Ó¼º ¾à
  • long acting sulfonamide
    Áö¼Ó¼º ¼³ÆÄÁ¦
  • long bone
    ±ä »À, Àå°ñ
    »çÁö¿¡¼­ º¸´Â »À·Î¼­ ´ëÅð°ñ, ºñ°ñ, °æ°ñ µîÀÌ ÀÖ´Ù.
  • long buccal nerve
    ÀåÇù ½Å°æ
  • long cure
    Àú¿Â Àå½Ã°£ ¿Â¼º¹ý
    160'F ¹°¿¡¼­ 8¡­9½Ã°£ µ¿¾È ¹æÄ¡ÇÏ´Â ¿Â¼º¹ýÀÌ´Ù. ÃßõÇÒ¸¸ÇÑ ¹æ¹ýÀÌ´Ù.
  • long dental appointment
    Àå½Ã°£ÀÇ Ä¡°ú Ä¡·á
  • long distance irradiation
    ¿ø°Ý Á¶»ç, ¿ø°Ý Á¶»ç¹ý
  • long history
    ¿À·¡µÈ º´·Â
  • long pin porcelain facing
    Àåħ ÀüÀå µµÄ¡
  • long sight
    ¿ø½Ã
    µ¿ÀǾî=hy
  • long term illness
    Àå±â Áúȯ
  • long tract syndrome
    Àå°æ·Î ÁõÈıº
  • long-acting nitrates
    Àå½Ã°£ ÀÛ¿ëÇÏ´Â Áú»ê¿°
  • long-standing
    Àå±âÀÇ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
long-lived Having a long life; having constitutional peculiarities which make long life probable; lasting long; as, a long-lived tree; they are a longlived family; long-lived prejudices.
Source: Websters Dictionary
(01 Mar 1998)
B-lymphocytes Lymphoid cells concerned with humoral immunity. They are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.
(12 Dec 1998)
CD4-positive T-lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the t4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes, which includes both the helper-inducer (T-lymphocytes, helper-inducer) and suppressor-inducer (T-lymphocytes, suppressor-inducer) T-cells.
(12 Dec 1998)
CD8-positive T-lymphocytes A critical subpopulation of regulatory T-lymphocytes involved in MHC class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-lymphocytes, cytotoxic) and suppressor T-lymphocytes (T-lymphocytes, suppressor-effector).
(12 Dec 1998)
T-lymphocytes Lymphoid cells concerned with cell-mediated immunity. They originate from lymphoid stem cells that migrate from the bone marrow to the thymus and differentiate under the influence of the thymic hormones. Various subpopulations have been described.
(12 Dec 1998)
T-lymphocytes, cytotoxic Immunised T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (mlc), in vivo during a graft-versus-host (gvh) reaction, or after immunization with an allograft, tumour cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (cml). These cells are distinct from natural killer cells (killer cells, natural) and from killer cells mediating antibody-dependent cell cytotoxicity.
(12 Dec 1998)
T-lymphocytes, helper-inducer Subpopulation of CD4+ lymphocytes that cooperate with other lymphocytes (either t or b) to initiate a variety of immune functions. For example, helper-inducer T-cells cooperate with B-cells to produce antibodies to thymus-dependent antigens and with other subpopulations of T-cells to initiate a variety of cell-mediated immune functions.
(12 Dec 1998)
T-lymphocytes, suppressor-effector Subpopulation of CD8+ T-lymphocytes which suppress antibody production or inhibit cellular immune responses. Suppressor-effector cells execute the message received from suppressor-inducer cells (T-lymphocytes, suppressor-inducer).
(12 Dec 1998)
T-lymphocytes, suppressor-inducer Subpopulation of CD4+ lymphocytes which induce CD8+ suppressor T-cells (T-lymphocytes, suppressor-effector) to suppress antibody production by B-cells. They also stimulate other cellular immune responses.
(12 Dec 1998)
lymphocytes White blood cells that fight infection and disease.
(12 Dec 1998)
lymphocytes, null A class of lymphocytes characterised by the lack of surface markers specific for either t or b lymphocytes.
(12 Dec 1998)
lymphocytes, tumour-infiltrating Lymphocytes that show specificity for autologous tumour cells. Ex vivo isolation and culturing of til with interleukin-2, followed by reinfusion into the patient, is one form of adoptive immunotherapy of cancer.
(12 Dec 1998)
HIV long-terminal repeat Regulatory sequences important for viral replication that are located on each end of the HIV genome. The ltr includes the HIV enhancer, promoter, and other sequences. Specific regions in the ltr include the negative regulatory element (nre), nf-kappa b binding sites , sp1 binding sites, tata box, and trans-acting responsive element (tar). The binding of both cellular and viral proteins to these regions regulates HIV transcription.
(12 Dec 1998)
segment long spacing <biochemistry> Abnormal packing pattern of collagen molecules formed if ATP is added to acidic collagen solutions, in which lateral aggregates of molecules are produced.
Each aggregate is 300 nm long and the molecules are all in register. If segment long spacing aggregates are overlapped with a quarter stagger, the 67 nm banding pattern of normal fibrils is reconstituted.
Acronym: SLS
(18 Nov 1997)
insurance, long-term care Health insurance to provide full or partial coverage for long-term home care services or for long-term nursing care provided in a residential facility such as a nursing home.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • short-lived
    ÀϽÃÀûÀÎ
  • lived
    »ý¸íÀÌ ...ÇÑ
  • a long-distance call
    Àå°Å¸® ÀüÈ­
  • before long
    °ð
  • long
    ±ä,±æ°Ô,¿À·§µ¿¾È,¿µ±¸È÷
  • long for
    °¥¸ÁÇÏ´Ù
  • long-distance call
    Àå°Å¸®(½Ã¿Ü)ÀüÈ­
  • long-drawn
    ±æ°Ô ´ÃÀÎ
  • long-drawn-out
    ±æ°Ô ´ÃÀÎ
  • so long !
    ¾È³ç
  • so long as ~
    ~ÇÏ´Â µ¿¾È,~ÇÏ´ÂÇÑ,~Çϱ⸸ Çϸé
  • E.long.
    east longitude
  • Long Beach
    ¹Ì±¹ Los Angeles ±Ù±³ÀÇ µµ½Ã;ÇØ¼ö¿åÀå
  • Long Island
    ·Õ ¼¶(¹Ì±¹ New YorkÁÖ ³²µµºÎÀÇ ¼¶)
  • Long Island Slund
    ·Õ ¾Æ¸±·£µå »ç¿îµå
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á